| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.31 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.31 | 0.04 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |